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Abstract
We conducted probabilistic data linkage of three population datasets for the Northern
Territory (NT), Australia, to describe the incidence of preterm births, stillbirths, low birth-
weight and small for gestational age (SGA) per 1000 NT births; and influenza and pertussis
hospitalisations per 1 00 000 NT births in infants <7 months of age, in a pre-maternal vaccin-
ation era. The Perinatal Trends dataset (1994–2014) formed the cohort of 78 382 births.
Aboriginal mother–infant pairs (37%) had disproportionately higher average annual rates
(AR) for all adverse birth outcomes compared to their non-Aboriginal counterparts; rate
ratios: preterm births 2.2 (AR 142.4 vs. 64.7); stillbirths 2.3 (AR 10.8 vs. 4.6); low birthweight
2.9 (AR 54 vs. 19); and SGA 1.7 (AR 187 vs. 111). Hospitalisation (2000–2015) and
Immunisation Register datasets (1994–2015), showed that influenza hospitalisations (n = 53)
and rates were 42.3 times higher in Aboriginal infants (AR 254 vs. 6); and that pertussis hospi-
talisations (n = 37) were 7.1 times higher in Aboriginal infants (AR 142.5 vs. 20.2) compared to
non-Aboriginal infants. These baseline data are essential to assess the safety and effectiveness of
influenza and pertussis vaccinations in pregnant women from the NT. Remote living Aboriginal
women and infants stand to benefit the most from these vaccines.
Introduction
Globally, pregnant women, particularly indigenous pregnant women and their infants, experi-
ence severe health consequences from influenza and pertussis infections compared to the gen-
eral population [1, 2]. Two vaccines are routinely recommended in pregnancy in Australia to
combat the high disease burden from these infections; inactivated influenza vaccine (IIV) and
diphtheria-Tetanus-acellular pertussis (dTpa) [3]. Seasonal IIV was first recommended in
pregnancy for Australian women in 2000, although not funded (provided for free) until
2010, [3] whilst dTpa (pertussis) vaccination in pregnancy was recommended and funded
by the states and territories in 2015 [4].
Despite these recommendations, systematic programs to monitor the uptake, safety and
effectiveness of IIV and pertussis vaccines in pregnancy remain absent. To determine the
safety and effectiveness of vaccination in pregnancy, it is critical to quantify the baseline
rates of adverse birth outcomes and the disease burden from influenza and pertussis infections
in early infancy in a pre-maternal vaccination uptake era. A World Health Organization
(WHO) report has stressed that baseline information on the safety of immunisation during
pregnancy is essential in order to distinguish between vaccine benefits and safety concerns
in local populations [5].
In Australia, pregnant women and Aboriginal and/or Torres Strait Islander (hereafter
respectfully referred to as Aboriginal*) women and their infants are over-represented in noti-
fication and hospitalisation rates and intensive care unit (ICU) admissions for influenza and
pertussis infections [6, 7]. The Northern Territory (NT) of Australia is geographically vast
(1.42 million km2) yet has a relatively small population (∼245 000) who are substantively
younger and compared to the rest of Australia, have the highest population proportion who
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S0950268819001171
Downloaded from https://www.cambridge.org/core. Australian National University, on 02 Oct 2019 at 00:46:21, subject to the Cambridge Core terms of use, available at
identify as Aboriginal [8, 9]. Small studies have found Aboriginal
women and infants living in remote and very remote regions of
the NT incur disproportionately higher rates of adverse birth out-
comes compared to non-Aboriginal women and infants, [10] and
little is known about the severity and geographic distribution of
influenza and pertussis infections in infants spanning the intro-
duction of IIV and pertussis vaccination in pregnancy.
Note: *In the Northern Territory, ‘Aboriginal’ is the preferred
official term for inclusively referring to both Aboriginal and
Torres Strait Islander peoples. This respectfully acknowledges
the relatively small percentage of the NT population who identify
as Torres Strait Islanders and the greater proportion of these peo-
ple who also identify as Aboriginal [11].
In the NT between 2008 and 2012, laboratory-confirmed influ-
enza infection notification rates were consistently highest in
women of child-bearing age and Aboriginal children in the
0–<5 years age group [12]. Despite the higher disease burden of
influenza in these groups and recommendations, uptake of IIV
in pregnancy amongst NT women was very low (∼<5%) prior
to the 2009 pandemic [13] and has remained low thereafter at
∼30% from 2014 [14]. Influenza vaccination is not licensed, nor
recommended for use in infants <6 months of age. These infants
can only be protected against influenza infection via maternal
antibody transfer if IIV is given to the mother during pregnancy
[15]. Several randomised controlled trials and observational stud-
ies have demonstrated that IIV in pregnancy is effective in redu-
cing influenza infection in pregnant women and infants [16–18].
For infants to be considered protected against pertussis
infection, the Australian National Immunisation Program (NIP)
currently recommends a three-dose primary infant pertussis
vaccination schedule; at 6–8 weeks, at 4 months and at 6 months
of age [3]. Despite this schedule\ and high levels of vaccine uptake
(>90%) in infancy, [19] pertussis notifications and hospitalisa-
tions remain highest in infants <4 months of age, [20] and are
consistently higher in Aboriginal infants compared to non-
Aboriginal infants [21, 22]. As a result of the high mortality
and morbidity in infants too young to be fully protected from
routine immunisation, administration of a pertussis-containing
vaccine was recommended in the UK and the USA for all
women in the third trimester of every pregnancy to confer early
infant protection, via maternal antibody transfer [23, 24]. This
strategy was found to be ∼95% effective in reducing pertussis
infections in infants <4 months of age in these countries [25,
26]. Based on these findings, the maternal pertussis vaccination
program was recommended in Australia and subsequently imple-
mented in the NT from April 2015 [4].
We aimed to describe the baseline incidence of adverse birth
outcomes for the whole of the NT population by year of infant
birth, remoteness and Indigenous status; we also aimed to
describe the baseline incidence, severity and geographic variation
of influenza and pertussis hospitalisations in infants from birth to
6 months of life by Indigenous status and region in a pre-maternal
vaccination uptake era.
Methods
Study design
We used three de-identified, unit-record linked whole of NT
population administrative datasets from the Developmental
Outcomes of Children in the NT study, [11] to conduct retro-
spective cohort analyses.
Study population
Our cohort encompassed all recorded NT births from 01 January
1994 to 31 December 2014 inclusive. This time period meant the
birth cohort was expected to be vaccine naïve for either IIV or
pertussis vaccines in pregnancy. The maternal pertussis vaccin-
ation program did not commence until April 2015 and there
was a very small proportion of IIV uptake in pregnancy recorded
during the 2009 H1N1 influenza pandemic until 2011 (<5%) [13].
Uptake of IIV in pregnancy in the NT is lacking for 2012 and
there was an estimated uptake of ∼15–30% from 2013 onwards
[14, 27].
Data sources
1. The NT Perinatal Trends dataset (perinatal dataset) encompassed
a whole of NT population birth cohort from 01 January 1994 to
31 December 2014 inclusive. These data were used to establish
the study cohort. Missing data were treated as such.
2. The NT Hospital Inpatient Activity dataset (hospitalisation
dataset) records all episodes of care for patients admitted to
all NT hospitals. Our dataset captured all episodes of hospitali-
sations from 01 July 2000 to 31 December 2015 inclusive. We
examined infant hospitalisations where a diagnosis of influenza
and/or pertussis was recorded, based on the Australian modified
International Statistical Classification of Diseases and Related
Problems (ICD-10-AM) codes, for infants born in the NT
whose mother had a record in the perinatal dataset [28].
3. The NT Immunisation register (NTIR) captured all episodes of
vaccinations administered in the NT from 01 January 1994 to
31 December 2015. Immunisation status was ascertained for
recommended scheduled vaccines in hospitalised infants with
an ICD-10-AM diagnosis of influenza and pertussis.
Data linkage and preparation
A mix of deterministic and probabilistic linkage was used to
match records from NT administrative datasets in health, educa-
tion and welfare services for all children born between 01 January
1994 and 31 December 2014. This established the whole cohort
for the Developmental Outcomes of Children in the NT study
[11] and became the data repository from which we drew our
study population. A unique project-specific linkage key (PSLK)
was generated for each child in the repository, which enabled
linkage of individual records across all datasets in the repository.
The perinatal dataset defined our study cohort and the PSLK was
used to link these infants to their hospitalisation and immunisa-
tion records as needed for analysis. Duplicate records for infants
in the hospitalisation and NTIR datasets were identified. Mothers
in the perinatal dataset had a unique identifier which could
be used to distinguish multiple and subsequent births, including
siblings. Both the NT and Commonwealth Departments of
Health (DoH) report Indigenous status of infants based on the
Indigeneity of the mother. As such, we have assigned Indigeneity
of the infant the same way [29, 30].
Remoteness
Australian Bureau of Statistics (ABS) geographical classifications
were used to compare demographic characteristics and birth out-
comes by degrees of remoteness in the NT: Outer Regional,
Remote and Very remote [31]. The NT has no major cities or
inner regional areas by ABS definition. Comparisons of infant
influenza and pertussis hospitalisations were conducted between
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the two major health service regions of the NT: Top End and
Central Australia (CA) due to the large geographical distance
between the two (∼1400 km) and distinctly different climates.
The Top End is considered monsoonal with two seasons-dry
and wet, whilst CA has extreme temperature variations and a
dry, arid environment.
Inclusion/exclusion criteria
Infants in the hospitalisation and immunisation datasets who had
no perinatal record were excluded from the cohort. Infants were
excluded from being ‘at-risk’ of a hospitalisation if they had no
record in the immunisation dataset indicating at least one vaccin-
ation episode in the first 12 months of life. Our reasoning was that
evidence of health service activity in the 12 month period after
birth constituted ongoing NT residency. Hospitalisation and
immunisation records were excluded from the study cohort if
infants were >12 months of age at the time of the encounter.
Statistical methods and data analysis
The perinatal dataset was used to calculate proportions for mater-
nal and infant demographic characteristics, maternal comorbid-
ities and risk factors and birth outcomes and to calculate the
incidence of adverse birth outcomes over the 20-year observation
period. These factors were analysed by Indigenous status, region
and remoteness. For continuous variables, means and medians
were calculated depending on the distribution of the data.
Birth outcomes
The birth outcomes of interest were: preterm births, stillbirths,
low birthweight infants at term (LBWT) and small for gestational
age (SGA). Infants born before 37 completed weeks’ gestation
were defined as preterm, [30] and stillborn infants were defined
as showing no signs of life after a pregnancy of at least 20
weeks gestation or weighing 400 g or more [32]. Infant birth-
weight <2500 grams was defined as low birthweight (LBW) in
accordance with the WHO definition [33]. As preterm birth is
the main contributor to LBW [34], we restricted LBW to include
singleton infants born at term; 37 completed weeks’ gestation
(LBWT). Small for gestational age (birthweight lower than the
10th percentile), was calculated using Australian national birth-
weight percentiles by sex and gestational age [35].
Infant hospitalisations
Following data linkage, the infant outcomes of interest were the
proportion and rate of hospitalisation for influenza and pertussis
infections, calculated by year of infant birth, Indigenous status
and remoteness for the first 6 completed months of life. Of spe-
cific interest was the number and rate of infant hospitalisations
for influenza during the 2009 influenza A (H1N1) pandemic.
The following ICD-10-AM codes were used when searching for
diagnoses in all hospitalisation episodes: influenza, J09-J11; per-
tussis, A37- A37.9. Infant age in weeks at hospital admission,
number of days hospitalised, ICU admissions and geographic dis-
tribution of hospitalisation were calculated.
Average annual incidence rates
Average annual incidence rates (AR) for preterm births, stillbirths,
LBWT and SGA were calculated per 1000 NT births, by year of
infant birth, Indigenous status and remoteness. Rate ratios were
calculated to compare rates between Aboriginal and non-
Aboriginal (referent group) infants. Average annual incidence
rates (AR) of infant influenza and pertussis hospitalisations
were calculated per 1 00 000 NT population for infant age in
weeks at time of hospitalisation, by year of infant birth,
Indigenous status and by region. Rate ratios were calculated to
compare rates between Aboriginal and non-Aboriginal (referent
group) infants. As hospitalisations were only captured from 01
July 2000 onwards, infants born before 2000 were excluded
from these analyses to prevent truncation bias. The total number
of infant births from 01 July 2000 to 30 July 2014 was used as the
denominator to calculate infant hospitalisation rates in weeks.
Table 1. Birth outcomes and average annual ratesa for Northern Territory women and infants, by Indigenous status, Australia (1994–2014)
Characteristics N (%) Total 76 489 Aboriginal (N = 28 158) Non-Aboriginal (N = 48 309) Incident rate ratiosf (range)
Median gestation in weeks (range) 39 (20–44) 39 (20–44) n/a
Mean birthweight in grams (range) 3098 (400–5834) 3355 (400–5980) n/a
Remote living 20 258 (74%) 7717 (16%) n/a
Preterm birthb 4014 (14%) 3117 (6%)
Average annual rate 142.4 64.7 2.2 (1.7–2.7)
Low birthweight at termc 1352 (5%) 986 (2%)
Average annual rate 54 19 2.9 (2.0–4.2)
Small for gestational aged 5240 (19%) 5165 (11%)
Average annual rate 187 111 1.7 (1.3–2.1)
Stillbirthse 399 (1.39%) 321 (0.65%)
Average annual rate 10.8 4.6 2.3 (1.3–4.3)
Note: Results do not include data for 22 infants with unknown Indigenous status. Singleton births only.
aRates per 1000 Northern Territory births.
b<37 completed weeks gestation.
c<2500 grams and ⩾37 weeks gestation.
d<10th percentile for Australian infants by sex.
e⩾20 weeks gestation and ⩾400grams.
fReferent group- non-Aboriginal infants.
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Data were analysed using Stata v.14.1 (StataCorp, College Station,
Texas) and graphs and figures were constructed using Microsoft
Excel and Stata v.14.1.
Ethics approvals
This project was approved by the NT DoH/ Menzies School of
Health Research (Menzies) Human Research Ethics Committee
(HREC) reference number: 2017–2749, the DoH/Menzies Top
End HREC, reference number: 2015–2333, the Central Australian
HREC, reference number: 15–293, the Steering Committee of the
Developmental Outcomes of Children in the NT study comprising
key NT government agencies and the Aboriginal Medical Services
Alliance of the NT (AMSANT). A stipulation of ethics approvals
precluded the reporting of cell sizes <5.
Results
Study cohort
Based on the perinatal dataset, 47 220 individual women birthed
78 382 infants between 01 April 1994 and 31 December 2014
(Fig. 1). Data on maternal Indigenous status was >99% complete
and 28 715 (37%) of infants had mothers who identified as an
Aboriginal woman.
Most births were singleton (n = 76 489, 98%) with no difference
between Aboriginal and non-Aboriginal mothers (98% vs. 97%).
There were 1 878 sets of twins (2%) and 15 sets of triplets
(<1%). We excluded 2 665 infants who did not have a record show-
ing at least one vaccination episode in the first 12 months of life as
per protocol because of lack of evidence of ongoing NT residency.
There were 56 903 infant hospitalisations; 13 350 newborn admis-
sions and 10 852 admissions for infants aged 7 months or older
were not included as per protocol. Of the remaining 33 141 hospi-
talisations, Indigenous status was known for 32 701 infants (99%)
and of these infants, 23 042 (70%) were Aboriginal.
Demographic characteristics
Most mother–infant pairs (63%) were from Outer regional areas;
37% were from Remote/Very remote areas. The mean maternal
age of women at infant birth was 27 years (range 12–51 years)
and 53% presented for antenatal care in the first trimester of preg-
nancy. Compared to Outer regional living women, women who
lived in Remote/Very remote areas were younger, less likely to
Fig. 1. Data linkage study cohort for Northern Territory mothers
and infants, Australia 1994–2015, inclusive. ^Individual infants
included in the respective datasets who were born 1994–2015
inclusive. *Merged dataset contained uniquely identified infants
from one or more of the available datasets, linked using Project
Specific Linkage Key. †Infants were excluded from the final
cohort if they did not have a linked perinatal record.
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present for antenatal care in the first trimester and more likely to
experience co-morbidities and have high-risk factors. Most women
(74%), were Aboriginal compared to 16% non-Aboriginal (Tables
S1 and S2).
Birth outcomes
The median gestational age at birth of infants was 39 weeks and
mean birthweight was 3253 grams. There was no clinically
important variation in these birth outcomes by Indigenous status
(Table 1) however, for preterm births, LBWT, SGA and stillbirths,
proportions and AR were consistently higher for Aboriginal
women compared to non-Aboriginal women (Table 1). In both
groups, there was a decreasing trendline throughout the study
period for LBWT, SGA and stillbirths (Fig. 2), however, the
decreasing trend for preterm births that was observed for
non-Aboriginal women was incongruent to an increasing trend
for Aboriginal women (Fig. 3).
Influenza and pertussis hospitalisations
Among 51 297 infants born in the 2000–2015 cohort, 15 346
(30%) were hospitalised at least once (33 141 episodes) before
the age of 7 months. There were 57 infants hospitalised for influ-
enza (0.2%) and 41 for pertussis (0.1%). There were nine deaths
and 67% of these were Aboriginal infants from Remote/Very
remote regions of the NT (data not shown elsewhere).
Influenza
Most infants hospitalised for influenza were Aboriginal (n = 51,
96%), with a median age at admission of 17 weeks (range <1–
30) and 91% (n = 48) lived in a Remote/Very remote setting.
More infants were hospitalised with influenza in the Top End
(n = 36, 68%) than in Central Australia (CA) (n = 17, 32%) and
the majority of these infants were Aboriginal (34/36, 94%),
(Table 2). The AR of influenza hospitalisations was 43 (range
0–46.4) times higher in Aboriginal infants compared to
non-Aboriginal infants (259 vs. 6), (Fig. 4).
2009 Influenza A (H1N1) pandemic
The NT recorded its first case of H1N1 pandemic influenza in
May 2009 [36]. Subsequently, 2009 saw the highest number of
infant influenza hospitalisations recorded throughout the study
period (22/57, 39%; Figure 5). All 22 of these hospitalisations
occurred in Aboriginal infants, with 19/22 (86%) among infants
living in Remote areas and 13/22 (59%) born during the
Southern Hemisphere influenza season.
Pertussis hospitalisations
Of the 41 pertussis hospitalisations, four infants (10%) had unknown
Indigenous status and none had received a pertussis-containing
vaccine as part of their infant schedule prior to hospitalisation.
Of the remaining 37 infants with a known Indigenous status,
most hospitalised for pertussis were Aboriginal (n = 30/37,
81%); had not received any pertussis-containing vaccines prior
to hospitalisation (30/37, 81%), were Remote/Very remote living
(n = 25/37, 68%) (Table 3). Nearly all Aboriginal infants had an
older sibling, (26/30, 87%) compared to less than half of
non-Aboriginal infants (3/7, 43%). Most pertussis hospitalisations
occurred predominantly in the first 4 months of life (Fig. 6). The
AR of pertussis hospitalisations was 7.1 (range 0–17.1) times
higher among Aboriginal infants compared to non-Aboriginal
infants (142.5 vs. 20.2), particularly evident during the national
epidemic years 2001, 2008 and 2011 (Figs 7 and 8).
Discussion
This is the largest linked whole of population cohort of 78 382
mother–infant pairs from the NT of Australia to date, of which
a substantial proportion (∼37%) are Aboriginal. There are few
whole of population studies with comparable long term data on
Aboriginal and remote-living populations. Baseline observed inci-
dence rates of adverse birth outcomes and infant influenza and
pertussis hospitalisations in a pre-maternal vaccination period
were all disproportionately higher amongst Aboriginal infants
than non-Aboriginal infants. These data are critical in order to
monitor disease surveillance, assess vaccine effectiveness and
evaluate the safety of the NT maternal influenza and pertussis
vaccination programs. Given the size of our cohort, these data
will provide a valuable future reference.
Birth outcomes
Though there was a disparity in the incidence for all adverse birth
outcomes between Aboriginal and non-Aboriginal women and
infants, apart from preterm births, there was a reassuring down-
ward trend over the observation period. The upward trend in pre-
term births experienced by Aboriginal women is concerning. It is
unclear whether this upward trend is an artefact of improvements
in survival rates of very preterm and extremely preterm infants
who historically experienced higher mortality rates or a true
increase due to persisting high levels of co-morbidities and risk
factors among Aboriginal women. Remoteness of living is a
known risk factor for adverse birth outcomes including preterm
birth [10], and our data supports this. Women with the highest
preterm birth rates were Remote living Aboriginal women, who
also had more co-morbidities and risk factors recorded for pre-
term birth, such as low attendance of first-trimester antenatal
care, maternal anaemia, urinary tract infections, sexually trans-
missible infections and smoking. Socioeconomic factors play a
major role in these high rates of co-morbidities and risk factors
for Aboriginal women and an improvement in the quality and
appropriateness of antenatal care provided to Remote living
Aboriginal women has been recommended as a way of reducing
these disproportionately high adverse birth outcomes [37].
Infant influenza and pertussis hospitalisations
Our results confirm the heavy burden of illness from influenza
infection in young Aboriginal infants, particularly during pandemic
years. There is potential to reduce the number of infant hospitalisa-
tions, the length of stay in hospital and ICU admissions, particularly
among Remote living Aboriginal infants under 6 months of age, by
improving the uptake of IIV in pregnancy [38, 39]. The uptake of
IIV in pregnancy remains poor in the NT and Australia wide,
[40, 41] despite being recommended and funded for many years.
It is unclear whether uptake is so poor due to the vaccine not
being offered to pregnant women, vaccine refusal or failure to
record vaccination receipt. There is recent evidence to suggest that
the introduction of the maternal pertussis vaccination program
has been the impetus for driving up IIV uptake in pregnancy
since its implementation in 2015 [42] although the data are lacking
for NT Aboriginal women and sample sizes for Aboriginal women
in other states were small or absent [40, 43].
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Fig. 2. Low birthweight, small for gestational age and
stillbirth rates per 1000 Northern Territory births,
Australia (1994–2014).
Fig. 3. Preterm birth rates per 1000 Northern Territory
births, Australia (1994–2014).
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Fig. 4. Influenza hospitalisation rates per 100 000 live
births for infants 0–<7 months old, by week of infant
birth, Northern Territory, Australia (2000–2014).
Table 2. Influenza hospitalisations for Northern Territory infants 0–<7 months of life, by region (2000–2015)
Characteristics Total N = 53 Top End n = 36/53 (68%) Central Australia n = 17/53 (32%)
Aboriginal 51 (96%) 34 (67%) 17 (33%)
Age at admission in weeksa,b (range) 17 (<1–30) 14 (2–30) 22 (<1–30)
Length of stay in daysa (range) 5 (1–339) 5 (1–339) 5 (1–55)
ICU admissions <5 cellsc 0 <5 cellsc
Remote/very remote living 48 (91%) 32/48 (67%) 16/48 (33%)
Preterm 11 (21%) 9 (82%) <5 cellsc
Low birthweight at term <5 cellsc 0 <5 cellsc
SGA <5 cellsc <5 cellsc <5 cellsc
aMedian values, based on non-parametric distribution of data.
bCensored at 6 completed months of infant life.
cActual numbers not shown if cells had <5 results.
Fig. 5. Influenza hospitalisation rates in 0–<7 month old
infants, by year of infant birth in the Northern Territory,
Australia (2000–2014).
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Infants <7 m hospitalised with pertussis infections in this
study were either unvaccinated with a pertussis-containing vac-
cine during their infancy or were too young to have completed
at least two doses of a pertussis-containing vaccine in order to
confer adequate protection from infection. A review of pertussis
hospitalisations is warranted post implementation of the maternal
vaccination program, with the expectation that there should be a
decrease in notifications and hospitalisations in these youngest
infants, given the 91–95% vaccine effectiveness that has been
demonstrated elsewhere [23, 25] and provided adequate vaccine
uptake in pregnancy is achieved. Pertussis vaccination in preg-
nancy could be particularly beneficial for Remote living
Aboriginal mothers and infants from the Top End, as the disease
burden was clearly highest in this population. To achieve this
reduction in disease burden, the maternal vaccination program
must be promoted and delivered in a culturally appropriate and
respectful way [44, 45].
Limitations
We acknowledge the potential biases that may arise from using
routinely collected administrative data and the risk of their poten-
tial accuracy, as a limitation [46]. The impact of these limitations
has been minimised through careful selection of the most reliable
Table 3. Pertussis hospitalisations for Northern Territory infants 0–<7 months of life, by Indigenous status and region (2000–2015)
Characteristics Total N = 37 Top End n = 24/37 (65%) Central Australia n = 13/37 (35%)
Aboriginal 30 (81%) 19 (63%) 11 (37%)
Age at admission in weeksa,b (range) 11 (3–30) 11 (3–30) 10 (6–16)
Length of stay in daysa (range) 5 (1–48) 5 (1–48) 4 (1–19)
ICU admissions <5 cellsc <5 cellsc 0
Pertussis vaccination statusd 7 (19%) 7/24 (29%) 0
Remote/very remote living 25 (68%) 19/25 (76%) 6/25 (24%)
Preterm 6 (16%) 6/37 0
Low birthweight at term <5 cellsc <5 cellsc <5 cellsc
SGA 12 (21%) 6/12 (50%) 6/12 (50%)
Note: excludes four infants with unknown Indigenous status and unknown region.
aMedian values, based on non-parametric distribution of data.
bCensored at 6 completed months of infant life.
cActual numbers not shown if cells have <5.
dPercent vaccinated with a pertussis-containing vaccine prior to hospitalisation.
Fig. 6. Number of pertussis hospitalisations in 0–<7 month old infants, by age in weeks of infant at time of hospitalisation and recommended pertussis vaccination
schedule, Northern Territory, Australia (2000–2014).
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variables, restriction of data to avoid selection bias and the use of
statistical techniques appropriate to observational data. The data
integrating authority used for this study, SANT DataLink, reports
>99% accuracy of its data linkage, based on reviews of all outputs
using nationally agreed data quality checks [47]. Any potential
mismatches in the linkage process are unlikely to have any impact
on the representativeness of this whole of population observa-
tional study.
Notification data for pertussis and influenza infections were
not included in the datasets, however, given hospitalisation is
an indication of disease severity, the results from our large
study can be used to infer the burden of severe disease in the
NT by age, remoteness, region and Indigeneity. Further, while
the small number of actual infant influenza and pertussis hospi-
talisations is a limitation, clearly the burden was heaviest for
remote living Aboriginal infants from the Top End. The inability
Fig. 7. Pertussis hospitalisation rates per 100 000 live births in 0–<7 month old infants, by year of infant birth at time of hospitalisation, Northern Territory, Australia
(2000–2014).
Fig. 8. Pertussis hospitalisation rates per 100 000 live births in 0–<7 month old infants, by age in weeks of infant at time of hospitalisation, Northern Territory,
Australia (2000–2014).
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to capture the infants who would have moved to the region is a
limitation of any birth cohort but is unlikely to have significantly
impacted the data.
The NTIR did not record information for maternal vaccin-
ation status until 2010, given IIV in pregnancy was only recom-
mended and not part of the funded scheduled immunisation
program prior to this time. Unknown maternal vaccination status
is, therefore, a limitation. There may be a small proportion of
pregnant females aged 15–17 years from 2003 onwards (∼<2%)
who received a pertussis vaccination inadvertently as part of the
school-aged dTpa booster vaccination program [3] however, we
anticipate the actual number vaccinated to be low. There may
also be a small proportion of Aboriginal females aged ⩾15
years from 2008 onwards (∼11%) who received seasonal IIV in
pregnancy as part of the annual recommended program for
Aboriginal peoples, [48] although again we anticipate actual num-
bers of women who were vaccinated in pregnancy to be very low.
Conclusion
We contribute whole of NT population baseline data for adverse
birth outcomes and influenza and pertussis infections in early
infancy in a pre-maternal vaccination era. Our study population
comprises robust representativeness of Aboriginal and remote-
living mother–infant pairs, demonstrating that Aboriginal
women and infants potentially stand to benefit the most from
maternal IIV and pertussis vaccination programs. In order to
evaluate the impact of the maternal IIV and pertussis vaccination
program of the NT, a subsequent review of the outcomes analysed
in this paper, along with an assessment of vaccine uptake in preg-
nancy is required in the future.
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